S Chawla1. 1. Classified Specialist (Obstetrics & Gynaecology), Base Hospital, New Delhi-10.
Abstract
BACKGROUND: Endometriosis is encountered in 7-10% of actively menstruating women, with a suspected prevalence as high as 22% in asymptomatic women. It is an important cause of chronic pelvic pain. The aim of this study was to evaluate the efficacy and safety of letrozole in combination with norethindrone acetate and calcium in the management of endometriosis associated pelvic pain. METHODS: Prospective non-randomized open label study was carried out including 20 patients with endometriosis related pelvic pain that was refractory to previous treatments. RESULT: In all 14 patients completed the study. All patients showed significant improvement of pain scores and revealed significant improvement of features of endometriosis on being given letrozole in combination with norethindrone acetate and calcium. CONCLUSION: Letrozole is an effective drug for treatment of endometriosis.
BACKGROUND:Endometriosis is encountered in 7-10% of actively menstruating women, with a suspected prevalence as high as 22% in asymptomatic women. It is an important cause of chronic pelvic pain. The aim of this study was to evaluate the efficacy and safety of letrozole in combination with norethindrone acetate and calcium in the management of endometriosis associated pelvic pain. METHODS: Prospective non-randomized open label study was carried out including 20 patients with endometriosis related pelvic pain that was refractory to previous treatments. RESULT: In all 14 patients completed the study. All patients showed significant improvement of pain scores and revealed significant improvement of features of endometriosis on being given letrozole in combination with norethindrone acetate and calcium. CONCLUSION:Letrozole is an effective drug for treatment of endometriosis.
Authors: Lisa L Amsterdam; William Gentry; Smeta Jobanputra; Michael Wolf; Stephen D Rubin; Serdar E Bulun Journal: Fertil Steril Date: 2005-08 Impact factor: 7.329
Authors: Stacey A Missmer; Frank Tu; Ahmed M Soliman; Stephanie Chiuve; Sarah Cross; Samantha Eichner; Oscar Antunez Flores; Andrew Horne; Beth Schneider; Sawsan As-Sanie Journal: BMJ Open Date: 2022-04-27 Impact factor: 3.006